Oxford Nanopore Technologies Ltd (ONT) - Net Assets
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has net assets worth GBX463.30 Million GBX (≈ $56.37K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX622.50 Million ≈ $75.74K USD) and total liabilities (GBX159.20 Million ≈ $19.37K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Oxford Nanopore Technologies Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX463.30 Million |
| % of Total Assets | 74.43% |
| Annual Growth Rate | 18.69% |
| 5-Year Change | -34.19% |
| 10-Year Change | 218.99% |
| Growth Volatility | 77.95 |
Oxford Nanopore Technologies Ltd - Net Assets Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Oxford Nanopore Technologies Ltd asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual net assets of Oxford Nanopore Technologies Ltd from 2012 to 2025. For live valuation and market cap data, see ONT company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX463.30 Million ≈ $56.37K |
-20.98% |
| 2024-12-31 | GBX586.34 Million ≈ $71.34K |
-8.93% |
| 2023-12-31 | GBX643.85 Million ≈ $78.34K |
-7.17% |
| 2022-12-31 | GBX693.56 Million ≈ $84.39K |
-1.48% |
| 2021-12-31 | GBX703.98 Million ≈ $85.65K |
+278.62% |
| 2020-12-31 | GBX185.93 Million ≈ $22.62K |
+69.76% |
| 2019-12-31 | GBX109.53 Million ≈ $13.33K |
-23.35% |
| 2018-12-31 | GBX142.89 Million ≈ $17.39K |
+52.69% |
| 2017-12-31 | GBX93.58 Million ≈ $11.39K |
-35.57% |
| 2016-12-31 | GBX145.24 Million ≈ $17.67K |
+44.54% |
| 2015-12-31 | GBX100.48 Million ≈ $12.23K |
+52.20% |
| 2014-12-31 | GBX66.02 Million ≈ $8.03K |
+0.38% |
| 2013-12-31 | GBX65.77 Million ≈ $8.00K |
+31.71% |
| 2012-12-31 | GBX49.94 Million ≈ $6.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Oxford Nanopore Technologies Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 49468763100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX100.00K | 0.02% |
| Other Comprehensive Income | GBX227.70 Million | 49.15% |
| Other Components | GBX786.40 Million | 169.74% |
| Total Equity | GBX463.30 Million | 100.00% |
Oxford Nanopore Technologies Ltd Competitors by Market Cap
The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LZ Technology Holdings Limited Class B Ordinary Shares
NASDAQ:LZMH
|
$13.88 Million |
|
Soditech SA
PA:SEC
|
$13.88 Million |
|
Schulte-Schlagbaum AG
DU:SSS
|
$13.88 Million |
|
SSH Group Ltd
AU:SSH
|
$13.88 Million |
|
CSH Alliance Bhd
KLSE:7165
|
$13.87 Million |
|
Temple Bar Investment Trust
LSE:TMPL
|
$13.87 Million |
|
Nusa Palapa Gemilang PT Tbk
JK:NPGF
|
$13.86 Million |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
$13.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Oxford Nanopore Technologies Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 586,338,000 to 463,300,000, a change of -123,038,000 (-21.0%).
- Net loss of 145,200,000 reduced equity.
- Other comprehensive income increased equity by 19,193,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-145.20 Million | -31.34% |
| Other Comprehensive Income | GBX19.19 Million | +4.14% |
| Other Changes | GBX2.97 Million | +0.64% |
| Total Change | GBX- | -20.98% |
Book Value vs Market Value Analysis
This analysis compares Oxford Nanopore Technologies Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 244.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 905.81x to 244.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | GBX0.13 | GBX117.90 | x |
| 2013-12-31 | GBX0.16 | GBX117.90 | x |
| 2014-12-31 | GBX0.15 | GBX117.90 | x |
| 2015-12-31 | GBX0.20 | GBX117.90 | x |
| 2016-12-31 | GBX0.27 | GBX117.90 | x |
| 2017-12-31 | GBX0.17 | GBX117.90 | x |
| 2018-12-31 | GBX0.18 | GBX117.90 | x |
| 2019-12-31 | GBX0.14 | GBX117.90 | x |
| 2020-12-31 | GBX0.23 | GBX117.90 | x |
| 2021-12-31 | GBX0.86 | GBX117.90 | x |
| 2022-12-31 | GBX0.84 | GBX117.90 | x |
| 2023-12-31 | GBX0.77 | GBX117.90 | x |
| 2024-12-31 | GBX0.65 | GBX117.90 | x |
| 2025-12-31 | GBX0.48 | GBX117.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Oxford Nanopore Technologies Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -31.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -64.85%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 1.34x
- Recent ROE (-31.34%) is above the historical average (-37.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -38.37% | -12816.49% | 0.00x | 1.04x | GBX-24.15 Million |
| 2013 | -36.93% | 0.00% | 0.00x | 1.05x | GBX-30.77 Million |
| 2014 | -56.36% | 0.00% | 0.00x | 1.07x | GBX-43.53 Million |
| 2015 | -38.62% | -5162.33% | 0.01x | 1.09x | GBX-48.48 Million |
| 2016 | -40.98% | -1304.95% | 0.03x | 1.10x | GBX-73.52 Million |
| 2017 | -60.41% | -410.07% | 0.12x | 1.27x | GBX-65.89 Million |
| 2018 | -37.17% | -163.34% | 0.19x | 1.23x | GBX-67.41 Million |
| 2019 | -65.93% | -138.71% | 0.32x | 1.50x | GBX-83.17 Million |
| 2020 | -32.94% | -53.79% | 0.40x | 1.51x | GBX-79.84 Million |
| 2021 | -23.81% | -125.40% | 0.16x | 1.20x | GBX-238.01 Million |
| 2022 | -13.12% | -45.83% | 0.24x | 1.19x | GBX-160.38 Million |
| 2023 | -24.00% | -91.06% | 0.22x | 1.21x | GBX-218.89 Million |
| 2024 | -24.93% | -79.80% | 0.25x | 1.27x | GBX-204.82 Million |
| 2025 | -31.34% | -64.85% | 0.36x | 1.34x | GBX-191.53 Million |
Industry Comparison
This section compares Oxford Nanopore Technologies Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $8,864,748
- Average return on equity (ROE) among peers: -251.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Oxford Nanopore Technologies Ltd (ONT) | GBX463.30 Million | -38.37% | 0.34x | $13.88 Million |
| 4BASEBIO UK SOCIETAS (4BB) | $7.12 Million | -72.33% | 0.64x | $951.45K |
| Aptamer Group PLC (APTA) | $245.81K | -274.50% | 4.65x | $205.09K |
| Arecor Therapeutics PLC (AREC) | $5.35 Million | -191.36% | 0.63x | $303.20K |
| Avacta Group PLC (AVCT) | $29.89 Million | -21.30% | 0.06x | $3.99 Million |
| BSF Enterprise Plc (BSFA) | $3.58 Million | -25.96% | 0.13x | $27.33K |
| Bioventix (BVXP) | $11.01 Million | 51.43% | 0.08x | $1.10 Million |
| Cizzle Biotechnology Holdings PLC (CIZ) | $32.00K | -956.25% | 1.81x | $127.81K |
| Amur Minerals Corporation (CRTX) | $20.48 Million | -8.91% | 0.04x | $80.26K |
| Fusion Antibodies PLC (FAB) | $50.13K | -935.06% | 5.06x | $193.60K |
| Faron Pharmaceuticals Oy (FARN) | $10.88 Million | -85.40% | 0.59x | $575.13K |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hard… Read more